Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
Johannes KloseStefan TrefzTobias WagnerLuca SteffenArsalie Preißendörfer CharrierPraveen RadhakrishnanClaudia VolzThomas SchmidtAlexis UlrichSebastian M DieterClaudia BallHanno GlimmMartin SchneiderPublished in: PloS one (2019)
Collectively, the results of this pre-clinical study indicate that salinomycin alone or in combination with 5-fluorouracil and oxaliplatin exerts increased antitumoral activity compared to common chemotherapy.